After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, GILD falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. The current market capitalization of Gilead Sciences, Inc is $142.44B. A total of 5.63 million shares were traded on the day, compared to an average of 7.75M shares.
In the most recent transaction, O’Day Daniel Patrick sold 10,000 shares of GILD for 113.94 per share on Jul 28 ’25. After the transaction, the Chairman & CEO now owns 605,725 company shares. In a previous transaction on Jul 28 ’25, DANIEL ODAY bought 10,000 shares at 113.94 per share.
Among the insiders who sold shares, Mercier Johanna disposed of 3,000 shares on Jul 15 ’25 at a per-share price of $111.03. This resulted in the Chief Commercial Officer holding 117,168 shares of GILD after the transaction. In another insider transaction, Dickinson Andrew D sold 2,500 shares at $111.03 per share on Jul 15 ’25. Company shares held by the Chief Financial Officer now total 162,610.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Gilead Sciences, Inc pays an annual dividend of $3.12, resulting in a dividend yield of 2.72%, and it has a price to earnings (P/E) ratio of 24.08.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, GILD has a high of $119.96 and a low of $72.43.
As of this writing, GILD has an earnings estimate of $1.96 per share for the current quarter. EPS was calculated based on a consensus of 23.0 estimates, with a high estimate of $2.05 per share and a lower estimate of $1.86.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. GILD’s latest balance sheet shows that the firm has $6.52B in Cash & Short Term Investments as of fiscal 2021. There were $26.70B in debt and $11.61B in liabilities at the time. Its Book Value Per Share was $15.39, while its Total Shareholder’s Equity was $21.06B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
